Anebulo Pharmaceuticals, Inc. logo

Anebulo Pharmaceuticals, Inc.

NASDAQ:ANEB

Overview | Financials
Company Name Anebulo Pharmaceuticals, Inc.
Symbol ANEB
Currency USD
Price 1.14
Market Cap 46,836,558
Dividend Yield 0%
52-week-range 0.8 - 3.2
Industry Biotechnology
Sector Healthcare
CEO Dr. Joseph F. Lawler M.D., Ph.D.
Website https://www.anebulo.com

An error occurred while fetching data.

About Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based

Related Stocks

HCW Biologics Inc. logo

HCW Biologics Inc.

HCWB

6.9 USD

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

UTRS

0 USD

TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc.

TCRX

1.6 USD

Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc.

GALT

1.32 USD

Eyenovia, Inc. logo

Eyenovia, Inc.

EYEN

1.09 USD

Centogene N.V. logo

Centogene N.V.

CNTG

0.325 USD

Augmedix, Inc. logo

Augmedix, Inc.

AUGX

2.345 USD

Viracta Therapeutics, Inc. logo

Viracta Therapeutics, Inc.

VIRX

0.022 USD

Financials

Numbers are in millions USD

Numbers are in millions USD